Lawtons Drugs

lawtons.ca

As a parent company and a strong supporter of Lawtons Drugs, Sobeys core values reflect the commitment and convictions that have helped shape the company over the past 100 years. Since our 1907 beginning as a small pharmacy in Newfoundland, Lawtons Drugs has portrayed integrity, commitment to its employees, and a desire to consistently exceed customer expectations in service, value and product selection. Lawtons Drugs has since grown to 80 locations in Atlantic Canada with plans to expand even further. Our pharmacy services complement customers’ prescriptions and help them manage their family’s medication and health care needs. Lawtons Drugs has a full line of home healthcare solutions, beauty, cosmetics, convenience and giftware products to suit everyone’s needs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

ASTORG TO ACQUIRE GLOBAL MEDICAL COMMUNICATIONS AND MARKET ACCESS PLATFORM OPEN HEALTH FROM AMULET CAPITAL PARTNERS

Astorg and Amulet Capital Partners | June 01, 2022

news image

Astorg and Amulet Capital Partners announce that they have signed a binding agreement whereby Astorg will acquire OPEN Health, a leading global provider of scientific communications and market access services to the pharmaceutical industry. Established in 2011 and headquartered in London, UK, OPEN Health is a key partner to its customers in helping them develop strategies for evidence generation and data communication by leveraging their extensive scientific knowledge and relentle...

Read More

PHARMACY MARKET

VENENO TECHNOLOGIES, A NOVEL DRP DRUG DISCOVERY COMPANY, RAISES $2MILLION (¥200M YEN) IN SEED FUNDING ROUND

Veneno Technologies Co. Ltd. | January 27, 2022

news image

Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to SBI Investment Co., Ltd., Tsukuba Institute of Research, Ltd., and SBI regional activation support Co., Ltd. The funds raised will be used to strengthen the recruitment and organizational structure, to further develop the Company's proprietary peptide drug discovery platform technology, and invest in the research and develop...

Read More

BUSINESS INSIGHTS

INNOCOLL ANNOUNCES PUBLICATION OF POSITIVE RESULTS FROM PIVOTAL CLINICAL TRIAL OF POSIMIR IN ARTHROSCOPIC SUBACROMIAL DECOMPRESSION

Innocoll Pharmaceuticals | July 07, 2022

news image

Innocoll Pharmaceuticals Limited, a commercial-stage biotechnology company and portfolio business of Gurnet Point Capital, announced the publication of the results of Study BU-002-IM evaluating the safety and efficacy of POSIMIR® for infiltration use in 107 patients undergoing arthroscopic subacromial decompression. The peer-reviewed paper, entitled “SABER-Bupivacaine Reduces Postoperative Pain and Opioid Consumption After Arthroscopic Subacromial Decompression: A Randomized, Placebo-C...

Read More

BUSINESS INSIGHTS

PHARMA TECH HOLDINGS SA OBTAINS A CAPITAL COMMITMENT AGREEMENT OF CHF 30 MILLION FROM GLOBAL INVESTOR LDA CAPITAL

Pharma Tech | August 09, 2022

news image

Pharma Tech Holding SA announced it has secured a CHF 30 million investment to support its portfolio investments from LDA Capital Ltd, a global investment group with expertise in cross border transactions including the agriculture, Agri-tech, and CBD industries. Established in 2019, PTH is a Swiss based holding company, which invests into innovative businesses with high technological value and scalability potential, mainly in Switzerland and Europe, with a focus on the health-tech...

Read More
news image

BUSINESS INSIGHTS

ASTORG TO ACQUIRE GLOBAL MEDICAL COMMUNICATIONS AND MARKET ACCESS PLATFORM OPEN HEALTH FROM AMULET CAPITAL PARTNERS

Astorg and Amulet Capital Partners | June 01, 2022

Astorg and Amulet Capital Partners announce that they have signed a binding agreement whereby Astorg will acquire OPEN Health, a leading global provider of scientific communications and market access services to the pharmaceutical industry. Established in 2011 and headquartered in London, UK, OPEN Health is a key partner to its customers in helping them develop strategies for evidence generation and data communication by leveraging their extensive scientific knowledge and relentle...

Read More
news image

PHARMACY MARKET

VENENO TECHNOLOGIES, A NOVEL DRP DRUG DISCOVERY COMPANY, RAISES $2MILLION (¥200M YEN) IN SEED FUNDING ROUND

Veneno Technologies Co. Ltd. | January 27, 2022

Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to SBI Investment Co., Ltd., Tsukuba Institute of Research, Ltd., and SBI regional activation support Co., Ltd. The funds raised will be used to strengthen the recruitment and organizational structure, to further develop the Company's proprietary peptide drug discovery platform technology, and invest in the research and develop...

Read More
news image

BUSINESS INSIGHTS

INNOCOLL ANNOUNCES PUBLICATION OF POSITIVE RESULTS FROM PIVOTAL CLINICAL TRIAL OF POSIMIR IN ARTHROSCOPIC SUBACROMIAL DECOMPRESSION

Innocoll Pharmaceuticals | July 07, 2022

Innocoll Pharmaceuticals Limited, a commercial-stage biotechnology company and portfolio business of Gurnet Point Capital, announced the publication of the results of Study BU-002-IM evaluating the safety and efficacy of POSIMIR® for infiltration use in 107 patients undergoing arthroscopic subacromial decompression. The peer-reviewed paper, entitled “SABER-Bupivacaine Reduces Postoperative Pain and Opioid Consumption After Arthroscopic Subacromial Decompression: A Randomized, Placebo-C...

Read More
news image

BUSINESS INSIGHTS

PHARMA TECH HOLDINGS SA OBTAINS A CAPITAL COMMITMENT AGREEMENT OF CHF 30 MILLION FROM GLOBAL INVESTOR LDA CAPITAL

Pharma Tech | August 09, 2022

Pharma Tech Holding SA announced it has secured a CHF 30 million investment to support its portfolio investments from LDA Capital Ltd, a global investment group with expertise in cross border transactions including the agriculture, Agri-tech, and CBD industries. Established in 2019, PTH is a Swiss based holding company, which invests into innovative businesses with high technological value and scalability potential, mainly in Switzerland and Europe, with a focus on the health-tech...

Read More